Aptevo Therapeutics: Q4 Earnings Insights

Aptevo Therapeutics APVO reported its Q4 earnings results on Thursday, March 24, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Aptevo Therapeutics missed estimated earnings by 3.1%, reporting an EPS of $-1.33 versus an estimate of $-1.29.

Revenue was up $1.29 million from the same period last year.

Last quarter the company beat on EPS by $0.04 which was followed by a 8.71% drop in the share price the next day.

Here's a look at Aptevo Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-1.47	-1.84	1.69	-1.32
EPS Actual	-1.43	-1.78	-1.74	-1.77
Revenue Estimate	3.65M	900.00K	2.42M	2.16M
Revenue Actual	3.10M	3.11M	2.42M	2.37M

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar